Jazz Pharms Inc Drug Patent Portfolio
Jazz Pharms Inc owns 1 orange book drug protected by 3 US patents Given below is the list of Jazz Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11085043 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
| US11236328 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
| US11746348 | Euglobulin-based method for determining the biological activity of defibrotide | 22 Jun, 2032 | Active |
Latest Legal Activities on Jazz Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Jazz Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent eGrant | 05 Sep, 2023 | US11746348 |
|
Email Notification
Critical
| 05 Sep, 2023 | US11746348 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746348 |
| Patent eGrant Notification | 05 Sep, 2023 | US11746348 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Sep, 2023 | US11746348 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Sep, 2023 | US11746348 |
|
Email Notification
Critical
| 18 Aug, 2023 | US11746348 |
|
Electronic Review
Critical
| 18 Aug, 2023 | US11746348 |
|
Issue Notification Mailed
Critical
| 16 Aug, 2023 | US11746348 |
|
Application Is Considered Ready for Issue
Critical
| 27 Jul, 2023 | US11746348 |
| Dispatch to FDC | 27 Jul, 2023 | US11746348 |
| Filing Receipt - Corrected | 17 Jul, 2023 | US11746348 |
|
Electronic Review
Critical
| 17 Jul, 2023 | US11746348 |
|
Email Notification
Critical
| 17 Jul, 2023 | US11746348 |
|
Issue Fee Payment Verified
Critical
| 12 Jul, 2023 | US11746348 |
Jazz Pharms Inc's Family Patents
Jazz Pharms Inc Drug List
Given below is the complete list of Jazz Pharms Inc's drugs and the patents protecting them.
1. Defitelio
Defitelio is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11085043 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(7 years from now)
| Active |
| US11236328 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(7 years from now)
| Active |
| US11746348 | Euglobulin-based method for determining the biological activity of defibrotide |
22 Jun, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Defitelio's drug page